Business Wire

CA Ventures Plans $500 Million Investment in European Housing

Share

Chicago-based CA Ventures today announced plans to invest $500 million over the next five years in the European housing market, specifically across the purpose-built student housing and multifamily apartment sectors.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180227006503/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

ARC at Old Colony (Chicago): CA Ventures transformed an existing office building into a 384-bed student housing community serving Illinois’ largest concentration of urban college campuses. (Photo: Business Wire)

A vertically integrated owner, developer and operator of apartments spanning all adult life stages, CA Ventures has a $6.7 billion portfolio comprising student housing, multifamily and senior living communities throughout the United States. Over the last eight years, the firm’s student housing entity, CA Student Living, has amassed a $3 billion portfolio serving over 40 universities in the U.S., Canada, Latin America and, now, Europe. During that same period, CA successfully sold over $2.5 billion of student accommodation assets. The firm’s strategy is to deliver highly amenitized, best-in-class near-campus properties in leading university markets, both nationally and internationally, where enrollments have increased and the housing supply has not kept pace.

“CA has been an innovator in student housing in the Americas for over a decade and, as a team, we’ve been evaluating the European housing market closely for several years,” said Tom Scott, CEO of CA Ventures. “We believe the market for purpose-built student housing in Europe is poised to benefit from growing university enrollments, increasing consumer adoption and a very limited supply of amenitized housing. As we are more than just capital, our capabilities as a vertically integrated developer and operator uniquely position us to bring our successful model to Europe, capitalizing on the scale and depth of these markets.”

The firm is currently developing two student housing projects in Poland – 700 beds in Krakow and 400 beds in Warsaw – and is in active negotiations to acquire properties and development sites in the U.K., the Netherlands, Germany, Spain, Ireland and the Czech Republic.

“As a pioneer of pedestrian-oriented, infill high-rise housing proximate to growing university populations, CA has delivered nearly 20,000 purpose-built student housing beds to date,” said JJ Smith, president of CA Student Living. “We have a strong track record of bringing a market-specific curation of building design, unit mix and amenity offerings to underserved university populations in the U.S. and internationally.”

“Across the geographically diverse markets in which we do business, student preferences are actually quite similar despite cultural nuances,” continued Smith. “Today’s students seek modern designs and conveniences such as fully furnished suites, private bedrooms and bathrooms, ample closet storage and a robust combination of well-appointed common spaces for social and academic pursuits. On-site management ties it all together with hands-on programming and a keen eye for safety protocols.”

According to Smith, Poland is a particularly attractive European market with strong enrollment growth from locals as well as students from other countries due to its high-quality, cross-discipline university programs offered in English. CA estimates that while nearly 50 percent of the 2 million university students in Poland do not live with their parents, there are less than 200,000 student housing beds currently available, much of it functionally obsolete.

“Broadly across Europe, less than a third of all students currently live in purpose-built student housing, so we see tremendous runway,” said Smith. “We have spent a significant amount of time researching specific markets, identifying landowners and pinpointing co-development partners looking to parlay their local expertise to a platform that de-risks their position and provides capital alongside design, development, construction management, leasing and operations expertise in the student accommodations sector. Already we have enjoyed great success and this is just the beginning. Our access to capital and ability to handle all aspects of development will allow us to move quickly to secure the best opportunities.”

About CA Ventures:

CA Ventures LLC is a Chicago-based real estate investment holding company whose international portfolio includes $7.8 billion in assets throughout the U.S., Canada and Latin America. While initially focused on student housing, CA Ventures has since diversified into other sectors, including office, senior living, multifamily, and hospitality. In addition to development and renovation, the firm specializes in institutional joint ventures; value add investing; equity and debt sourcing; and asset management services. CA Ventures serves as the holding company for the CA family of companies, including CA Student Living, CA Office / Vanderbilt Partners, CA Senior Living, CA Residential, CA International, and CA Hospitality. For more information, visit www.ca-ventures.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Taylor Johnson
Sara Williams, (312) 267-4510
swilliams@taylorjohnson.com
or
Abe Tekippe, (312) 267-4528
atekippe@taylorjohnson.com
or
CA Ventures LLC
JJ Smith, (312) 994-1882
jjsmith@ca-ventures.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SINOVAC Announces Record and Distribution Dates for Special Cash Dividend30.4.2025 09:00:00 EEST | Press release

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as previously announced on April 1, 2025, will be paid in cash to valid holders of SINOVAC’s common shares as of the close of business on May 23, 2025, ET. Such cash dividend is expected to be paid on or about July 9, 2025. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalificat

SES: Q1 2025 Results30.4.2025 08:30:00 EEST | Press release

SES S.A. announces financial results for the three months ended 31 March 2025. Revenue of €509 million (-0.5% yoy(1)) and Adjusted EBITDA(2) of €280 million (-0.9% yoy(1)), both growing excl. periodic impact Networks revenue up +8.4% yoy(1) including some periodic impact supported by growth in Government (+13.1% yoy(1)) and Mobility (+8.5% yoy(1)); Media (-10.6% yoy(1)) in-line with expectations €360 million of new business and contract renewals signed in Q1 2025 Net Leverage at 1.2x(3) (including cash & cash equivalents of €3.1 billion(4)) O3b mPOWER satellites 7&8 have reached final orbital position – boosting mPower network capacity and resilience from May FY 2025 financial outlook(5) on track with yoy stable Revenue and broadly stable Adjusted EBITDA re-affirmed Fully funded Intelsat acquisition anticipated to complete in H2 2025 – intention to optimise the combined debt structure On 3 April 2025, AGM approved all company recommended resolutions including prioritisation of sharehol

Geoswift Launches Visa Direct to Enhance Cross-Border Payment Offers in Over 30 Countries30.4.2025 04:00:00 EEST | Press release

Geoswift announced today the integration of Visa Direct with Geoswift's cross-border payments platform. Visa Direct facilitates payouts to more than 140 countries and territories. The integration will enable payouts in 32 countries and territories, across 13 currencies, covering major markets in Asia Pacific, North America, Europe and Middle East, with plans for more in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423288249/en/ Bryan Ma, SVP, Head of Geoswift Global Payments, and Swapnil Mhasde, Head of Visa Direct Commercialization and Solutions, Asia Pacific, celebrating the launch in Singapore. Geoswift is a leading provider of cross-border payment services and solutions globally. With over two decades of innovation, it has become a trusted name in B2B, education, eCommerce, remittance, and travel payment use cases. Raymond Qu, Group CEO of Geoswift, stated, "At Geoswift, our vision has always been to del

Logitech Announces Q4 and Full Fiscal Year 2025 Results29.4.2025 23:03:00 EEST | Press release

SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2025 ended March 31, 2025. For Fiscal Year 2025: Sales were $4.55 billion, up 6 percent in US dollars and 7 percent in constant currency, compared to the prior year. GAAP operating income was $655 million, up 11 percent compared to the prior year. Non-GAAP operating income was $775 million, up 11 percent compared to the prior year. GAAP earnings per share (EPS) was $4.13, up 7 percent compared to the prior year. Non-GAAP EPS was $4.84, up 14 percent compared to the prior year. Cash flow from operations was $843 million. The year-ending cash balance was $1.5 billion. The Company returned $797 million of cash to shareholders through its annual dividend payment and share repurchases. For Q4 Fiscal Year 2025: Sales were $1.01 billion, flat in US dollars and up 2 percent in constant currency, compared

U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene29.4.2025 22:32:00 EEST | Press release

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the U.S. Patent and Trademark Office (USPTO) rendered a Final Written Decision invalidating all claims of Pharmacyclics LLC’s (Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) that were challenged by BeiGene in a post-grant review (PGR) proceeding. On November 1, 2023, BeiGene filed a PGR petition with the USPTO challenging the validity of certain claims of the ‘803 patent, in response to a patent infringement lawsuit Pharmacyclics brought against BeiGene concerning BRUKINSA® (zanubrutinib). On May 1, 2024, the USPTO granted BeiGene’s petition to institute the PGR. The USPTO’s Final Written Decision is appealable by Pharmacyclics. Commenting on the ruling, BeiGene General Counsel Chan Lee said: “We are pleased that the USPTO invalidated all challenged claims of the ‘803 patent. Today’s decision reinforces our belief th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye